Trinitas Capital
5
67M
5
3
- Areas of investment
Summary
The fund was located in Asia if to be more exact in China. The leading representative office of defined VC is situated in the Beijing.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Analytics, Health Diagnostics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Vividion Therapeutics, Gritstone Oncology, Quanterix.
The top activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 50 - 100 millions dollars. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this Trinitas Capital works on 21 percentage points more the average amount of lead investments. The increased amount of exits for fund were in 2018.
The standard case for the fund is to invest in rounds with 9 partakers. Despite the Trinitas Capital, startups are often financed by The Column Group, Versant Ventures, In-Q-Tel. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, The Column Group, ARCH Venture Partners. In the next rounds fund is usually obtained by Topspin Partners, The Column Group, Taiho Ventures.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Exits
- 3
- Investments by industry
- Biotechnology (5)
- Health Care (4)
- Therapeutics (3)
- Pharmaceutical (2)
- Health Diagnostics (2) Show 3 more
- Investments by region
-
- United States (5)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 1.00
- Strategy success index
- 0.62
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Vividion Therapeutics | 30 Apr 2019 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 82M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.